|   | |
|   | |
| Clinical data | |
|---|---|
| ATC code | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H24N2 | 
| Molar mass | 280.415 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
|   (what is this?)    (verify) | |
Ibogamine is an anti-convulsant, anti-addictive, CNS stimulant alkaloid found in Tabernanthe iboga and Crepe Jasmine ( Tabernaemontana divaricata ). [1] [2] [3] Basic research related to how addiction affects the brain has used this chemical. [4]
Ibogamine persistently reduced the self-administration of cocaine and morphine in rats. [5] The same study found that ibogamine (40 mg/kg) and coronaridine (40 mg/kg) did not produce "any tremor effects in rats that differ significantly from saline control". While the related alkaloids ibogaine (20–40 mg/kg), harmaline (10–40 mg/kg) and desethylcoronaridine (10–40 mg/kg) were "obviously tremorgenic". [5]
Like ibogaine, it has seems to have similar pharmacology. It has effects on KOR, [6] NMDAR, nAChR [7] and serotonin sites. [8] It also inhibits acetylcholinesterase and butyrylcholinesterase. [9]
Ibogamine can be prepared from one-step demethoxycarbonylation process through coronaridine. [10]